Search

everythinglearnresearchcommunity

for

Search:↓

A shampoo with cannabidiol can significantly reduce scalp inflammation and symptoms in people with mild to moderate psoriasis or seborrheic dermatitis.

Extracellular vesicles show promise for treating psoriasis by reducing inflammation and skin lesions.

Ixekizumab is effective and safe for patients who did not improve with etanercept treatment for psoriasis.

Targeting the skin's endocannabinoid system could help treat skin disorders.

Anti-IL-12/IL-23 antibody therapy effectively treats psoriasiform skin lesions in IBD patients.

Abnormal growth factor metabolism may link psoriasis and metabolic syndrome, and obesity can affect psoriasis treatment effectiveness.

Tofacitinib helps improve skin conditions in people with Down syndrome, especially alopecia areata.

Vitiligo is often found with other autoimmune diseases, which is important to know to help patients.

Children with different rheumatologic diseases have specific skin symptoms that can help with diagnosis.

Patients with chronic skin conditions on systemic treatments did not have worse COVID-19 outcomes and could resume their treatments after recovery.

Defective repair processes may cause immune activation and inflammation in psoriatic disease.

Oral tofacitinib successfully treated total body hair loss in one patient.

Obesity affects skin health, causing conditions like acanthosis nigricans and may require different treatment approaches.

Skin diseases are common and can significantly affect people's lives; better outcome measures and ethical clinical trials are needed to improve dermatology care.

The document concludes that proper diagnosis and treatment of common scalp disorders are important for both physical and psychological health.

New psoriasis treatments are effective but come with side effects and risks.

New and repurposed treatments are improving outcomes in dermatology.

Psoriasis treatments range from topical creams to systemic medications with serious side effects, and while treatments can manage symptoms, there is no cure.

Nanoparticles improve drug delivery through the skin but more research is needed on their long-term effects and skin penetration challenges.

Using systemic drugs as creams for skin conditions shows promise, but more research is needed to confirm their effectiveness and safety.

Hair loss can indicate or worsen with systemic diseases, and treating the underlying condition is important.

Vitamin D is crucial for skin health and managing skin diseases.

Natural products like propolis are causing more skin allergies, and certain skin treatments and medications have various side effects and risks.

Cannabinoids may help some skin conditions but more research is needed.

Some systemic treatments work for nail psoriasis but can have serious side effects.

JAK inhibitors show promise for treating various skin diseases.

Improving education, training, and access to affordable treatments is crucial for better managing inflammatory skin diseases in Latin America.

Tofacitinib improved arthritis and partially improved hair loss in a lupus patient without side effects.

A woman's psoriasis improved after hepatitis C treatment with interferon, despite interferon's risk of worsening skin conditions.

Cannabinoids like CBD and THC may help treat non-cancer skin diseases, but more research is needed.